These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 23265840)
1. mTOR: on target for novel therapeutic strategies in the nervous system. Maiese K; Chong ZZ; Shang YC; Wang S Trends Mol Med; 2013 Jan; 19(1):51-60. PubMed ID: 23265840 [TBL] [Abstract][Full Text] [Related]
2. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders. Maiese K Br J Clin Pharmacol; 2016 Nov; 82(5):1245-1266. PubMed ID: 26469771 [TBL] [Abstract][Full Text] [Related]
3. Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade. Maiese K; Chong ZZ; Wang S; Shang YC Int J Mol Sci; 2012 Oct; 13(11):13830-66. PubMed ID: 23203037 [TBL] [Abstract][Full Text] [Related]
4. Taking aim at Alzheimer's disease through the mammalian target of rapamycin. Maiese K Ann Med; 2014 Dec; 46(8):587-96. PubMed ID: 25105207 [TBL] [Abstract][Full Text] [Related]
5. Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders. Chong ZZ; Shang YC; Zhang L; Wang S; Maiese K Oxid Med Cell Longev; 2010; 3(6):374-91. PubMed ID: 21307646 [TBL] [Abstract][Full Text] [Related]
6. Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin. Chong ZZ; Shang YC; Wang S; Maiese K Prog Neurobiol; 2012 Nov; 99(2):128-48. PubMed ID: 22980037 [TBL] [Abstract][Full Text] [Related]
7. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer. Maiese K Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811 [TBL] [Abstract][Full Text] [Related]
8. Role of mTOR in physiology and pathology of the nervous system. Swiech L; Perycz M; Malik A; Jaworski J Biochim Biophys Acta; 2008 Jan; 1784(1):116-32. PubMed ID: 17913600 [TBL] [Abstract][Full Text] [Related]
9. Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin. Maiese K Curr Neurovasc Res; 2017; 14(2):184-189. PubMed ID: 28294062 [TBL] [Abstract][Full Text] [Related]
11. Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration. Querfurth H; Lee HK Mol Neurodegener; 2021 Jul; 16(1):44. PubMed ID: 34215308 [TBL] [Abstract][Full Text] [Related]
12. Erythropoietin: new directions for the nervous system. Maiese K; Chong ZZ; Shang YC; Wang S Int J Mol Sci; 2012; 13(9):11102-11129. PubMed ID: 23109841 [TBL] [Abstract][Full Text] [Related]
13. The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease. Maiese K Curr Neurovasc Res; 2023; 20(3):314-333. PubMed ID: 37488757 [TBL] [Abstract][Full Text] [Related]
14. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways. Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250 [TBL] [Abstract][Full Text] [Related]
15. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR. Maiese K Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460 [TBL] [Abstract][Full Text] [Related]
16. Transforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis. Das R; Xu S; Nguyen TT; Quan X; Choi SK; Kim SJ; Lee EY; Cha SK; Park KS J Biol Chem; 2015 Dec; 290(52):30830-42. PubMed ID: 26565025 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous inhibition of mTORC1 and mTORC2 by mTOR kinase inhibitor AZD8055 induces autophagy and cell death in cancer cells. Sini P; James D; Chresta C; Guichard S Autophagy; 2010 May; 6(4):553-4. PubMed ID: 20364113 [TBL] [Abstract][Full Text] [Related]
18. PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. Thedieck K; Polak P; Kim ML; Molle KD; Cohen A; Jenö P; Arrieumerlou C; Hall MN PLoS One; 2007 Nov; 2(11):e1217. PubMed ID: 18030348 [TBL] [Abstract][Full Text] [Related]
19. Novel compounds for the modulation of mTOR and autophagy to treat neurodegenerative diseases. Heras-Sandoval D; Pérez-Rojas JM; Pedraza-Chaverri J Cell Signal; 2020 Jan; 65():109442. PubMed ID: 31639492 [TBL] [Abstract][Full Text] [Related]
20. Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. Huang J; Wu S; Wu CL; Manning BD Cancer Res; 2009 Aug; 69(15):6107-14. PubMed ID: 19602587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]